The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.

Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.

Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.

Peptides as short as hexamers, capable of forming amyloid fibrils, are anti-inflammatory agents and are therapeutic for autoimmune diseases and ischemia.

The formation of amyloid fibrils is associated with diseases such as Alzheimer's and Parkinson's, type II diabetes, amyloidosis, and prion associated disease. Stanford researchers have extended the list of indications to include inflammation associated wi...
more information »

Flagellin As An Immunostimulant

Researchers in Dr. James Swartz’s lab have developed a flagellin array that stimulates stronger and more rapid immune response. Vaccines may be helpful in preventing or treating a variety of diseases; however there are times when it is difficult for a ...
more information »

What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests for additional information. TechFinder contains text and images. TechFinder is updated within minutes of any changes made at Stanford's Office of Technology Licensing.